CONVATEC GROUP PLC Convatec Group PLC: Results of 2022 AGM – Update Statement

Directive transparence : information réglementée

23/09/2022 15:00

Convatec Group PLC (CTEC)
Convatec Group PLC: Results of 2022 AGM – Update Statement

23-Sep-2022 / 14:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

23 September 2022

Convatec Group Plc
("Convatec" or "the Company")

Results of 2022 AGM – Update Statement

While the Resolution to approve the Directors' Remuneration Report at the last AGM was passed, we acknowledge that a number of shareholders chose not to support this Resolution.

Prior to the AGM the Remuneration Committee consulted extensively with shareholders and following the AGM, the Remuneration Committee Chair wrote to our largest shareholders who voted against the Resolution to understand their reasons and to offer further engagement.

The Remuneration Committee is committed to positive engagement with shareholders and will be consulting further over the coming months in respect of the Company's forthcoming Remuneration Policy review.




Analysts and Investors 

Kate Postans, VP Investor Relations, Convatec                                                            +44 (0)782 644 7807 




Buchanan: Charles Ryland / Chris Lane                                                                         +44 (0)207 466 5000                                            

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 


About Convatec 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 250 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over $2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http://www.convatecgroup.com


Category Code: AGM
LEI Code: 213800LS272L4FIDOH92
Sequence No.: 189992
EQS News ID: 1448703

End of Announcement EQS News Service


30/09/2022 14:19
26/09/2022 15:00
23/09/2022 15:00
13/09/2022 13:08
16/08/2022 13:00